International Ophthalmology

, Volume 29, Issue 1, pp 61–62 | Cite as

Topical interferon α-2b as an adjunctive therapy in recurrent conjunctival papilloma

  • R. Muralidhar
  • Rajeev Sudan
  • Mandeep S. Bajaj
  • Vikas Sharma
Photographic Essay


Interferon Papilloma Amniotic Membrane Bare Area Carbon Dioxide Laser 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kanski JJ (1999) Disorders of the conjunctiva. In: Kanski JJ (eds) Clinical ophthalmology: a systematic approach. Butterworth Heinemann, pp 55–93Google Scholar
  2. 2.
    Sjo N, Heegaard S, Prause JU (2000) Conjunctival papilloma: a histopathologically based retrospective study. Acta Ophthalmol Scand 78:663–666CrossRefPubMedGoogle Scholar
  3. 3.
    Lass JH, Foster CS, Grove AS et al (1987) Interferon-alpha therapy of recurrent conjunctival papillomas. Am J Ophthalmol 103:294–301PubMedGoogle Scholar
  4. 4.
    Schechter BA, Rand WJ, Velazquez GE, Williams WD, Starasoler L (2002) Treatment of conjunctival papillomata with topical interferon Alfa-2b. Am J Ophthalmol 134(2):268–270CrossRefPubMedGoogle Scholar
  5. 5.
    de Keizer RJ, de Wolff-Rouendaal D (2003) Topical alpha-interferon in recurrent conjunctival papilloma. Acta Ophthalmol Scand 81:193–196CrossRefPubMedGoogle Scholar
  6. 6.
    Falco LA, Gruosso PJ, Skolnick K, Bejar L (2007) Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma. Optometry 78(4):162–166PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • R. Muralidhar
    • 1
  • Rajeev Sudan
    • 1
  • Mandeep S. Bajaj
    • 1
  • Vikas Sharma
    • 1
    • 2
  1. 1.Dr. Rajendra Prasad Centre for Ophthalmic SciencesAll India Institute of Medical SciencesNew DelhiIndia
  2. 2.Little Germany, Bradford City CentreUK

Personalised recommendations